news
Could stem cell therapy stabilise MS progression?
Positive findings from a first-in-human trial means that an advanced cell therapy for progressive multiple sclerosis will be evaluated in Phase II.
List view / Grid view
University of Cambridge
article
Recent developments in stem cell therapies
EPR explores recent developments in stem cell therapies across several hard-to-treat diseases and how technology is transforming ATMP manufacture.
news
First patient dosed with novel RNA modifying enzyme inhibitor
A Phase I trial for solid tumours has begun to assess STC-15, the first RNA methyltransferase modifying enzyme inhibitor.
news
UK research consortium given £2 million to control monkeypox
£2 million will help fund a UK team of scientific experts to research monkeypox, uncover novel treatments and curb the spread of the virus.
news
Are strategic partnerships the winning model for outsourcing?
A University of Cambridge report assessing the preferred relationship type between pharma and contract research organisations (CROs), showed strategic partnerships will continue as the primary collaboration model.
news
Further £8.4 million in funding given to UK researchers studying immune response to COVID-19
The funding is being split across three research projects that will hopefully improve the treatment of COVID-19 and inform the development of vaccines and therapeutics.
article
Stem cells in the clinic: how are they regulated?
Dr Roger Barker, University of Cambridge, UK and Eric Anthony, International Society for Stem Cell Research (ISSCR), describe how stem cells are regulated around the world and why this is important for patient safety.
news
Second patient cured of HIV using stem cell therapy
Researchers report that a patient who underwent stem-cell transplantation and a chemotherapy drug regimen has been cured of HIV.
news
Seizures could be stopped and prevented with implanted electronic device
Researchers have developed an electronic device which could help to detect, prevent and stop seizures from occurring in epileptic patients...
news
Senescent cells targeted with new nanocarrier drug delivery system
Senescent, or zombie cells, are being targeted with the development of a new nanocarrier drug delivery system.
news
JSM could lead to improved arthritis treatment
An algorithm to monitor the joints of patients with arthritis, which could change the way that the severity of the condition is assessed...
news
Anticholinergic medications linked to dementia
Long-term use of some anticholinergic medications are associated with an increased risk of dementia – according to a new study led by the University of East Anglia...
news
Method to predict drug stability could lead to more effective medicines
Researchers have developed a new method to predict the physical stability of drug candidates, which could help with the development of new and more effective medicines for patients...
news
£54 million funding to transform health through data science
Health Data Research UK is awarding £30 million funding to six sites across the UK to address challenging healthcare issues through the use of data science...
news
Triclosan may help fight drug-resistant malaria
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of the malaria parasite that have grown resistant to one of the currently used drugs...
